Tagged: Appointments

Joseph Guglielmo, PharmD, an honored UCSF professor and mentor as well as a leading pharmacist and clinical scientist specializing in antimicrobial therapies, will be the new dean of the UCSF School of Pharmacy.

Joseph Guglielmo, PharmD, has been named interim dean of the UCSF School of Pharmacy, and will take the reins of the school from outgoing Dean Mary Anne Koda-Kimble, PharmD, as of July 1.

UCSF School of Pharmacy Associate Dean of Teaching and Learning Tina Brock, BSPharm, MSPH, EdD, became president of the national pharmacy leadership society, Phi Lambda Sigma (

Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences (QB3) at

The office of Lisa Bero, PhD, on UCSF’s Laurel Heights campus has long been a key portal between the School of Pharmacy and the world at large, including countries where billions of people cannot get even the most vital life-saving drugs.

Michael Nordberg, MPA/HSA, is the newly appointed associate dean of administration and finance for the UCSF School of Pharmacy. He served the position as interim associate dean from July 1, 2009 to September 26, 2011 when he accepted the position full time at the completion of a comprehensive recruitment for the job.

Louis R. Cantilena, Jr., MD, PhD, is the newly appointed course director of the American Course on Drug Development and Regulatory Sciences (ACDRS) effective summer 2011.

Michael Williams, MA, is the first executive director of academic, administrative, and research technology for the UCSF School of Pharmacy, effective August 1, 2011.

Education researcher Tina Penick Brock, BSPharm, MSPH, EdD, has been appointed associate dean of teaching and learning in the UCSF School of Pharmacy, effective March 11, 2011. She serves as the point person for all matters in the School related to educational affairs.

Lisa Bero, PhD, a faculty member in the UCSF School of Pharmacy was named to represent The Cochrane Collaboration on the World Health Assembly of the World Health Organization (WHO) after the Collaboration was awarded an Assembly seat on January 23, 2011.